Guangzhou Concord Cancer Center

Proton therapy for breast cancer presents unique dosimetric challenges due to frequent use of range shifters and potential proton penetration into lungs. The study aims to compare dosimetric results between a novel proton treatment planning system (TPS) with...

To validate the accuracy of CuraProton, a newly developed proton therapy treatment planning system, through comprehensive type testing of depth dose distributions and transverse dose profiles across multiple clinically complex scenarios, in strict compliance...

Radiation dermatitis (RD) is a primary acute toxicity in proton therapy for H&N cancer patients. Since skin typically resides in the distal fall-off region of the posterior or posterior oblique beams, the radiobiological dose may increase and lead to more sev...